DXCM vs XYL · P/E 63, rev $2.50B vs P/E 27, rev $4.46B
DexCom Inc (DXCM) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the DXCM and XYL stock pages for the full models.
Not investment advice.